Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238

References

• Ultimo S, Martelli AM, Zauli G, et al. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia. J Cell Physiol. 2018 Aug;233:5642–5654.
   PubMed Web of Science ®Google Scholar
• Scheijen B, Boer JM, Marke R, et al. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. Haematologica. 2017 Mar;102(3):541–551.
   PubMed Web of Science ®Google Scholar
• Tuckuviene R, Ranta S, Albertsen BK, et al. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study. J Thromb Haemost. 2016 Mar;14(3):485–494.
   PubMed Web of Science ®Google Scholar
• Fernandes Q. MicroRNA: Defining a new niche in leukemia. Blood Rev. 2017 May;31(3):129–138.
   PubMed Web of Science ®Google Scholar
• Hackl H, Astanina K, Wieser R. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J Hematol Oncol. 2017 Feb 20;10(1):51.
   PubMedGoogle Scholar
• Zenz T, Habe S, Denzel T, et al. Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood. 2009 Sep 24;114(13):2589–2597.
   PubMed Web of Science ®Google Scholar
• Zauli G, Voltan R, di Iasio MG, et al. miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin Cancer Res. 2011 May 1;17(9):2712–2724.
   PubMed Web of Science ®Google Scholar
• De Luca L, Trino S, Laurenzana I, et al. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia. Cell Death Dis. 2017 Jun 1;8(6):e2849.
   PubMedGoogle Scholar
• Jian P, Li ZW, Fang TY, et al. Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol. 2011 Apr 25;4:20.
   PubMed Web of Science ®Google Scholar
• de Leeuw DC, Verhagen HJ, Denkers F, et al. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia. Leukemia. 2016 Mar;30(3):742–746.
   PubMed Web of Science ®Google Scholar
• Piatopoulou D, Avgeris M, Marmarinos A, et al. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. Br J Cancer. 2017 Sep 5;117(6):801–812.
   PubMed Web of Science ®Google Scholar
• Faraoni I, Laterza S, Ardiri D, et al. MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status. J Hematol Oncol. 2012 Jun 8;5:26.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Maharry KS, Metzeler KH, et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol. 2013 Jun 10;31(17):2086–2093.
   PubMed Web of Science ®Google Scholar
• Duyu M, Durmaz B, Gunduz C, et al. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia. Biomed Res Int. 2014;2014:1–7.
   Web of Science ®Google Scholar
• Meng Y, Tian H, Hu Q, et al. MicroRNA repertoire and comparative analysis of Andrias davidianus infected with ranavirus using deep sequencing. Dev Comp Immunol. 2018 Aug;85:108–114.
   PubMed Web of Science ®Google Scholar
• Liang YN, Tang YL, Ke ZY, et al. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor. J Steroid Biochem Mol Biol. 2017 Sep;172:62–68.
   PubMed Web of Science ®Google Scholar
• Yang JH, Li JH, Shao P, et al. Starbase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2011 Jan;39(Database issue):D202–D209.
   PubMedGoogle Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005 Jan 14;120(1):15–20.
   PubMed Web of Science ®Google Scholar
• Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005 May;37(5):495–500.
   PubMed Web of Science ®Google Scholar
• John B, Enright AJ, Aravin A, et al. Human MicroRNA targets. PLoS Biol. 2004 Nov;2(11):e363.
   PubMed Web of Science ®Google Scholar
• Kertesz M, Iovino N, Unnerstall U, et al. The role of site accessibility in microRNA target recognition. Nat Genet. 2007 Oct;39(10):1278–1284.
   PubMed Web of Science ®Google Scholar
• Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006 Sep 22;126(6):1203–1217.
   PubMed Web of Science ®Google Scholar
• Xie C, Mao X, Huang J, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011 Jul;39(Web Server issue):W316–W322.
   PubMedGoogle Scholar
• Fedele V, Dai F, Masilamani AP, et al. Epigenetic regulation of ZBTB18 promotes glioblastoma Progression. Mol Cancer Res. 2017 Aug;15(8):998–1011.
   PubMed Web of Science ®Google Scholar
• Tatard VM, Xiang C, Biegel JA, et al. ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth. Cancer Res. 2010 Feb 1;70(3):1236–1246.
   PubMed Web of Science ®Google Scholar
• Dzikiewicz-Krawczyk A, Macieja A, Maly E, et al. Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding. J Hematol Oncol. 2014 Jun 2;7:43.
   PubMed Web of Science ®Google Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015 Jun;15(6):321–333.
   PubMed Web of Science ®Google Scholar
• Fernando TR, Rodriguez-Malave NI, Rao DS. MicroRNAs in B cell development and malignancy. J Hematol Oncol. 2012;5:7.
   PubMed Web of Science ®Google Scholar
• Yeh CH, Moles R, Nicot C. Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer. 2016 May 14;15(1):37.
   PubMedGoogle Scholar
• Ferrajoli A, Shanafelt TD, Ivan C, et al. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013 Sep 12;122(11):1891–1899.
   PubMed Web of Science ®Google Scholar
• Diaz-Beya M, Brunet S, Nomdedeu J, et al. MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leukemia. 2014 Apr;28(4):804–812.
   PubMed Web of Science ®Google Scholar
• Narayan N, Morenos L, Phipson B, et al. Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia. Leukemia. 2017 Apr;31(4):808–820.
   PubMed Web of Science ®Google Scholar
• Cui B, Chen L, Zhang S, et al. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014 Jul 24;124(4):546–554.
   PubMed Web of Science ®Google Scholar
• Palma CA, Al Sheikha D, Lim TK, et al. MicroRNA-155 as an inducer of apoptosis and cell differentiation in acute myeloid Leukaemia. Mol Cancer. 2014 Apr 5;13:79.
   PubMed Web of Science ®Google Scholar
• Velu CS, Chaubey A, Phelan JD, et al. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. J Clin Invest. 2014 Jan;124(1):222–236.
   PubMed Web of Science ®Google Scholar
• Van Roosbroeck K, Fanini F, Setoyama T, et al. Combining anti-Mir-155 with chemotherapy for the treatment of lung cancers. Clin Cancer Res. 2017 Jun 1;23(11):2891–2904.
   PubMed Web of Science ®Google Scholar
• Ohtaka-Maruyama C, Hirai S, Miwa A, et al. RP58 regulates the multipolar-bipolar transition of newborn neurons in the developing cerebral cortex. Cell Rep. 2013 Feb 21;3(2):458–471.
   PubMed Web of Science ®Google Scholar
• Baubet V, Xiang C, Molczan A, et al. Rp58 is essential for the growth and patterning of the cerebellum and for glutamatergic and GABAergic neuron development. Development. 2012 Jun;139(11):1903–1909.
   PubMed Web of Science ®Google Scholar
• Xiang C, Baubet V, Pal S, et al. RP58/ZNF238 directly modulates proneurogenic gene levels and is required for neuronal differentiation and brain expansion. Cell Death Differ. 2012 Apr;19(4):692–702.
   PubMed Web of Science ®Google Scholar
• Hirai S, Miwa A, Ohtaka-Maruyama C, et al. RP58 controls neuron and astrocyte differentiation by downregulating the expression of Id1-4 genes in the developing cortex. EMBO J. 2012 Mar 7;31(5):1190–1202.
   PubMed Web of Science ®Google Scholar
• Heng JI, Qu Z, Ohtaka-Maruyama C, et al. The zinc finger transcription factor RP58 negatively regulates Rnd2 for the control of neuronal migration during cerebral cortical development. Cereb Cortex. 2015 Mar;25(3):806–816.
   PubMed Web of Science ®Google Scholar
• Nakagawa R, Leyland R, Meyer-Hermann M, et al. MicroRNA-155 controls affinity-based selection by protecting c-MYC+ B cells from apoptosis. J Clin Invest. 2016 Jan;126(1):377–388.
   PubMed Web of Science ®Google Scholar
• Skalsky RL, Samols MA, Plaisance KB, et al. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol. 2007 Dec;81(23):12836–12845.
   PubMed Web of Science ®Google Scholar
• Muylkens B, Coupeau D, Dambrine G, et al. Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch Virol. 2010 Nov;155(11):1823–1837.
   PubMed Web of Science ®Google Scholar
• Sahmatova L, Tankov S, Prans E, et al. MicroRNA-155 is Dysregulated in the Skin of patients with Vitiligo and inhibits Melanogenesis-associated genes in Melanocytes and Keratinocytes. Acta Derm Venereol. 2016 Aug 23;96(6):742–747.
   PubMed Web of Science ®Google Scholar
• Elton TS, Selemon H, Elton SM, et al. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013 Dec 10;532(1):1–12.
   PubMed Web of Science ®Google Scholar
• Pottier N, Maurin T, Chevalier B, et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PloS one. 2009 Aug 24;4(8):e6718.
   PubMed Web of Science ®Google Scholar
• Xie Q, Chen X, Lu F, et al. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer. 2012 May 1;118(9):2431–2442.
   PubMed Web of Science ®Google Scholar
• Yin Q, Wang X, Fewell C, et al. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol. 2010 Jul;84(13):6318–6327.
   PubMed Web of Science ®Google Scholar
• Chen C, Luo F, Yang Q, et al. NF-kappaB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite. Mol Carcinog. 2018 Apr;57(4):483–493.
   PubMed Web of Science ®Google Scholar
• He B, Gao SQ, Huang LD, et al. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking. Mol Med Rep. 2015 Mar;11(3):2355–2359.
   PubMed Web of Science ®Google Scholar